Evidence map›Paper›PMID 37304256›Full record

ArticleFrontiers in immunology2023

Leslie Landemaine, Gregory Da Costa, Elsa Fissier, Carine Francis, Stanislas Morand, Jonathan Verbeke, Marie-Laure Michel, Romain Briandet, Harry Sokol, Audrey Gueniche and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Atopic Dermatitis-like mouse model using early inoculation of patient-derivedJID innovations : skin science from molecules to population health · 2026
    Article
  9. The Evolution of Symbiosis inBiomolecules · 2026
    Review
  10. Article
  11. Article
  12. Review
  13. Life (Basel, Switzerland) · 2025
    Article
  14. Article
  15. Article
  16. The role of the AHR in host-pathogen interactions.Nature reviews. Immunology · 2025
    Review
  17. Review
  18. Article
  19. CommensalFrontiers in immunology · 2025
    Article
  20. Early skin colonization byFrontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 1 country.

Leslie LandemaineUniversité Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, France.
Gregory Da CostaUniversité Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, France.
Elsa FissierUniversité Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, France.
Carine FrancisL'Oréal Research and Innovation, Aulnay-sous-Bois, France.
Stanislas MorandL'Oréal Research and Innovation, Aulnay-sous-Bois, France.
Jonathan VerbekeiMEAN, Toulouse, France.
Marie-Laure MichelUniversité Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, France.
Romain BriandetUniversité Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, France.
Harry SokolParis Center for Microbiome Medicine (PaCeMM), Fédération Hospitalo-Universitaire, Paris, France.
Audrey GuenicheL'Oréal Research and Innovation, Chevilly-Larue, France.
Dominique BernardL'Oréal Research and Innovation, Aulnay-sous-Bois, France.
Jean-Marc ChatelUniversité Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, France.
Luc AguilarL'Oréal Research and Innovation, Aulnay-sous-Bois, France.
Philippe LangellaUniversité Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, France.
Cecile ClavaudL'Oréal Research and Innovation, Aulnay-sous-Bois, France.
Mathias L RichardUniversité Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, France.
L'Oréal (France) · FRInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · FRUniversité Paris-Saclay · FRAgroParisTech · FRAssistance Publique – Hôpitaux de Paris · FRFédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine · FRMicrobiologie de l’alimentation au service de la santé · FRToulouse Mathematics Institute · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: S Methods: For this purpose, a library of 12 strains originated from healthy skin (non-hyperseborrheic (NH) and hyperseborrheic (H) skin types) and disease skin (atopic (AD) skin type) was characterized at the genomic and phenotypic levels. Results and discussion: Here we showed that strains from atopic lesional skin alter the epidermis structure of a 3D reconstructed skin model whereas strains from NH healthy skin do not. All strains from NH healthy skin induced AhR/OVOL1 path and produced high quantities of indole metabolites in co-culture with NHEK; especially indole-3-aldehyde (IAld) and indole-3-lactic acid (ILA); while AD strains did not induce AhR/OVOL1 path but its inhibitor STAT6 and produced the lowest levels of indoles as compared to the other strains. As a consequence, strains from AD skin altered the differentiation markers FLG and DSG1. The results presented here, on a library of 12 strains, showed that

Indexed as

Dermatitis, AtopicStaphylococcus epidermidisHealth PromotionHumansReceptors, Aryl HydrocarbonSkinReceptors, Aryl Hydrocarbonaryl hydrocarbon receptorbiofilmsindolesinflammationproteasesS. epidermidisskin microbiomeskin type

Identifiers

PMID37304256
PMCPMC10250813
OpenAlexW4378473070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.